NanoGhost
1 known investors
NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.
Founders & leadership
MM
Marcelle MachlufProfessor (technology inventor)
Investors · 1
In the news
Frequently asked questions
- What does NanoGhost do?
- NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.
- Who founded NanoGhost?
- NanoGhost was founded by Marcelle Machluf.
- Who are NanoGhost's investors?
- NanoGhost's investors include aMoon.